title: A successful anticoagulation protocol for the first HeartMate II implantation in the United States.
abstract: Bleeding and thrombus formation are common problems with life-threatening implications in patients receiving a left ventricular assist device. We describe the anticoagulation protocol for the 1st patient in the United States to undergo successful implantation of the HeartMate II left ventricular assist system.
authors.affiliation: Department of Cardiopulmonary Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
authors.forename: Offer
authors.initials: O
authors.lastname: Amir
authors.forename: Arthur W
authors.initials: AW
authors.lastname: Bracey
authors.forename: Frank W
authors.initials: FW
authors.lastname: Smart
authors.forename: Reynolds M
authors.initials: RM
authors.lastname: Delgado
authors.forename: Nyma
authors.initials: N
authors.lastname: Shah
authors.forename: Biswajit
authors.initials: B
authors.lastname: Kar
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D000991:Antithrombins / Q000008:administration & dosage / Q000627:therapeutic use; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006353:Heart-Assist Devices; D006629:Hirudins / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use; D019919:Prosthesis Implantation / Q000009:adverse effects / Q000379:methods*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000628:therapy*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D003911:Dextrans; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin